-
Acetaminophen poisoning? New synthetic oligosaccharides to help
Heparan sulfate is widely present on the surface of all mammalian cells and interacts with a variety of important proteins. Therefore, drugs that targ...
2020-08-12 09:31 -
Global 500 pharmaceutical companies released
The most eye-catching change this year is undoubtedly the historic leapfrogging of mainland Chinese companies: the number of mainland Chinese (includi...
2020-08-11 15:13 -
How likely is the localization of Indian and American APIs?
Statistics of import and export goods released by the General Administration of Customs of China show that my country exported 5,446,100 tons of APIs ...
2020-08-11 09:57 -
The EU issued a formal ban on lambda-cyfluthrin
According to the announcement, the relevant preparation products should be withdrawn from the market within 6 months of the effective date of the anno...
2020-08-10 14:22 -
Speed up consistency evaluation in 2020? Injection is the main force
Since the outbreak of COVID-19 epidemic in February, the consistency evaluation work has been carried out, but the number of acceptance cases decrease...
2020-08-10 10:53 -
Nine kinds of drugs or meet the outbreak!
Among them, the long-term prescription drug list covers 137 varieties, and is divided into 9 categories of drugs, including hypertension, diabetes, dy...
2020-08-10 10:15 -
Locking down shape-shifting spike protein aids development of COVID-19 vaccine
The experimental vaccine against SARS-CoV-2 that was the first to enter human trials in the United States has been shown to elicit neutralizing antibo...
2020-08-10 10:00 -
Pfizer signs deal to manufacture Gilead's remdesivir
Pfizer Inc said on Friday it signed a multi-year agreement to manufacture Gilead Sciences Inc’s antiviral drug remdesivir for COVID-19 patients in a ...
2020-08-10 09:56 -
The raw material drug market is resurging, companies accelerate expansion
Since India restricted the export of some APIs in order to ensure the supply of domestic drugs in early March, China, as a major producer of APIs, fac...
2020-08-07 15:02 -
AstraZeneca takes COVID-19 vaccine to China with BioKangtai deal
AstraZeneca has signed a licensing agreement with China's BioKangtai, which will make the British pharma's COVID-19 vaccine for the Chinese market.
2020-08-07 15:01
Hot News
- Wanhua Signs 70K HDI Acquisiti... Apr 16, 2025
- Kuwait Petroleum subsidiary ac... Apr 27, 2025
- Global Chemical Supply Chain C... Apr 30, 2025
- BASF Divests Two Joint Venture... Apr 23, 2025
- UK Slashes Tariffs on 89 Produ... Apr 17, 2025
Related Products
Related Producers
